
Novel therapy could slow tumour growth, results find
A novel cancer therapy targeting tumour acidity could boost immune response and slow cancer growth, studies show. Biotechnology company Dyve Biosciences, in collaboration with Moffitt Cancer Center, reported results for a first-of-its-kind investigational therapy applied to the skin, which is designed to work throughout the body to target the tumour microenvironment –… Read More















